Partnering With WIC to Prevent Excessive Weight Gain in Pregnancy (NCT03707834) | Clinical Trial Compass
CompletedNot Applicable
Partnering With WIC to Prevent Excessive Weight Gain in Pregnancy
United States416 participantsStarted 2018-07-01
Plain-language summary
The purpose of this study is to determine the effect of an antenatal obesity treatment on gestational weight gain when integrated into Philadelphia WIC.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* BMI ≥ 25 kg/m2
* Self-identify as African American or Hispanic
* Gestational age ≤16 weeks' (measured using last menstrual period)
* Philadelphia WIC participant
* Willingness to receive study texts
* Own a cell phone with an unlimited text messaging plan
* Able to participate in light to moderate physical activity (walking)
Exclusion Criteria:
* Prior bariatric surgery
* Pre-existing medical condition that could influence weight (e.g., diabetes, HIV, thyroid disorder, bulimia, anorexia, gallbladder disease)
* Diagnosis contraindicating weight control (e.g., hyperemesis gravidarum)
* Shared phone
* Multiple pregnancy (e.g., twins)
* Current and/or previous participant for our Temple-led obesity treatment interventions in pregnancy or the postpartum period
* Serious or unstable medical or psychological conditions that, in the opinion of the PI, would compromise the subject's safety for successful participation in the study
What they're measuring
1
Percentage of Women With Excessive Gestational Weight Gain
Timeframe: End of Pregnancy (36-38 weeks' gestation)
2
Change in Maternal Weight
Timeframe: At baseline (<16 weeks' gestation) and End of Pregnancy (36-38 weeks' gestation)